{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:15:36Z","timestamp":1791274536589,"version":"4.1.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1136\/ard.2008.101766","type":"journal-article","created":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T20:24:55Z","timestamp":1229977495000},"page":"20-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":835,"title":["Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review"],"prefix":"10.1016","volume":"69","author":[{"given":"G","family":"Ruiz-Irastorza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ramos-Casals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Brito-Zeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Khamashta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1136\/ard.2008.101766_bib1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1177\/0961203396005001021","article-title":"The history of antimalarials.","volume":"5","author":"Wallace","year":"1996","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.2007.070367","article-title":"EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.","volume":"67","author":"Bertsias","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.101766_bib3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/0961203306071924","article-title":"Systemic lupus erythematosus in a multiethnic cohort (LUMINA XXXIX): relationship between hormone replacement therapy and disease activity over time.","volume":"15","author":"Fern\u00e1ndez","year":"2006","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib4","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1002\/art.21224","article-title":"Incidence and risk factors of thromboembolism in systemic lupus erythematosus: a comparison of three ethnic groups.","volume":"52","author":"Mok","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.101766_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/01.md.0000091181.93122.55","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients.","volume":"82","author":"Cervera","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ard.2008.101766_bib6","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1002\/art.20622","article-title":"Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Baseline predictors of vascular events.","volume":"50","author":"Toloza","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.101766_bib7","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","article-title":"Grading quality of evidence and strength of recommendations.","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.1136\/ard.2008.101766_bib8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1056\/NEJM199101173240303","article-title":"A randomized study of the effect of withdrawing hydroxychloroquine sulphate in systemic lupus erythematosus.","volume":"324","author":"The Canadian Hydroxychloroquine Study Group","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.101766_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/096120339600500313","article-title":"Controlled trial with chloroquine diphosphate in systemic lupus erythematosus.","volume":"5","author":"Mein\u00e3o","year":"1996","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib10","first-page":"1457","article-title":"Comparison of hydroxychloroquine and placebo in the treatment of the arthropathy of mild systemic lupus erythematosus.","volume":"21","author":"Williams","year":"1994","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.101766_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1191\/096120301678646137","article-title":"Hydroxychloroquine (HCQ) in lupus pregnancy: a double-blind and placebo-controlled study.","volume":"10","author":"Levy","year":"2001","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1191\/0961203306lu2299oa","article-title":"Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients.","volume":"15","author":"Wozniacka","year":"2006","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib13","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1002\/art.22156","article-title":"Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus.","volume":"54","author":"Costedoat-Chalumeau","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.101766_bib14","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1002\/art.22159","article-title":"Hydroxychloroquine in lupus pregnancy.","volume":"54","author":"Clowse","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.101766_bib15","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/rheumatology\/41.6.643","article-title":"Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies.","volume":"41","author":"Cort\u00e9s-Hern\u00e1ndez","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2008.101766_bib16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1191\/0961203306lu2271oa","article-title":"Sustained remission of lupus nephritis.","volume":"15","author":"Barber","year":"2006","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1191\/0961203306lu2313oa","article-title":"Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis.","volume":"15","author":"Kasitanon","year":"2006","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1191\/096120398678919778","article-title":"A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group.","volume":"7","author":"Tsakonas","year":"1998","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/09612033070160040901","article-title":"Chloroquine increases low-density lipoprotein removal from plasma in systemic lupus patients.","volume":"16","author":"Sachet","year":"2007","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00296-002-0266-z","article-title":"Polymorphism of the beta3-adrenergic receptor and lipid profile in patients with rheumatoid arthritis and systemic lupus erythematosus treated with chloroquine.","volume":"23","author":"Mu\u00f1oz-Valle","year":"2003","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard.2008.101766_bib21","first-page":"780","article-title":"Longterm beneficial effect of chloroquine diphosphate on lipoprotein profile in lupus patients with and without steroid therapy.","volume":"28","author":"Borba","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.101766_bib22","first-page":"2142","article-title":"Effect of antimalarial agents on the fasting lipid profile in systemic lupus erythematosus.","volume":"27","author":"Tam","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.101766_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1191\/096120300678828541","article-title":"Hydroxychloroquine has no significant effect on lipids and apolipoproteins in Chinese systemic lupus erythematosus patients with mild or inactive disease.","volume":"9","author":"Tam","year":"2000","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib24","first-page":"661","article-title":"The lipid, lipoprotein, and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythematosus.","volume":"20","author":"Hodis","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.101766_bib25","first-page":"325","article-title":"The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs.","volume":"26","author":"Rahman","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.101766_bib26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0002-9343(94)90151-1","article-title":"Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis.","volume":"96","author":"Petri","year":"1994","journal-title":"Am J Med"},{"key":"10.1136\/ard.2008.101766_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1479-8077.2007.00293.x","article-title":"Triglyceride and high-density lipoprotein levels as the markers of disease activity and their association with TNF\u03b1 and TNF receptor system in systemic lupus erythematosus.","volume":"10","author":"Karimifar","year":"2007","journal-title":"APLAR J Rheumatol"},{"key":"10.1136\/ard.2008.101766_bib28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/ard.2006.054973","article-title":"High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors.","volume":"66","author":"Chung","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.101766_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1191\/0961203305lu2039oa","article-title":"Bone mineral density in postmenopausal Chinese patients with systemic lupus erythematosus.","volume":"14","author":"Mok","year":"2005","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib30","first-page":"102","article-title":"Factors associated with low bone mineral density in female patients with systemic lupus erythematosus.","volume":"28","author":"Lakshminarayanan","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.101766_bib31","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1136\/ard.2005.040428","article-title":"Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study.","volume":"65","author":"Calvo-Al\u00e9n","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.101766_bib32","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0961203306075771","article-title":"The role of non-corticosteroid related factors in osteonecrosis (ON) in systemic lupus erythematosus: a nested case-control study of inception patients.","volume":"16","author":"Prasad","year":"2007","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib33","first-page":"2535","article-title":"Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia.","volume":"28","author":"Huisman","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.101766_bib34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/1529-0131(199901)42:1<51::AID-ANR7>3.0.CO;2-D","article-title":"Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus.","volume":"42","author":"Manzi","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.101766_bib35","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1161\/01.HYP.37.4.1075","article-title":"Vascular stiffness in women with systemic lupus erythematosus.","volume":"37","author":"Selzer","year":"2001","journal-title":"Hypertension"},{"key":"10.1136\/ard.2008.101766_bib36","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1056\/NEJMoa035471","article-title":"Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.","volume":"349","author":"Roman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.101766_bib37","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1590\/S1516-31802005000300010","article-title":"Atherosclerotic plaque in carotid arteries in systemic lupus erythematosus: frequency and associated risk factors.","volume":"123","author":"Souza","year":"2005","journal-title":"Sao Paulo Med J"},{"key":"10.1136\/ard.2008.101766_bib38","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1002\/art.21967","article-title":"Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.","volume":"54","author":"Von Feldt","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.101766_bib39","first-page":"2458","article-title":"Predictors of carotid atherosclerosis in systemic lupus erythematosus.","volume":"33","author":"Maksimowicz-McKinnon","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.101766_bib40","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/rheumatology\/kem002","article-title":"Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype.","volume":"46","author":"Ahmad","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2008.101766_bib41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1196\/annals.1422.003","article-title":"Vascular elasticity of systemic lupus erythematosus patients is associated with steroids and hydroxychloroquine treatment.","volume":"1108","author":"Tanay","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1136\/ard.2008.101766_bib42","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/art.1780301219","article-title":"Does hydroxychloroquine sulfate prevent clot formation in systemic lupus erythematosus?","volume":"30","author":"Wallace","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.101766_bib43","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1093\/rheumatology\/kei014","article-title":"Systemic lupus erythematosus in a multiethnic cohort (LUMINA): XXVIII. Factors predictive of thrombotic events.","volume":"44","author":"Ho","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2008.101766_bib44","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0961203306071872","article-title":"Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus.","volume":"15","author":"Ruiz-Irastorza","year":"2006","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib45","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/rheumatology\/41.8.924","article-title":"A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome.","volume":"41","author":"Erkan","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2008.101766_bib46","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0961203306069972","article-title":"Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus.","volume":"15","author":"de Leeuw","year":"2006","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/md.0b013e318123f888","article-title":"Risk and predictors of arterial thrombosis in lupus and non-lupus primary glomerulonephritis: a comparative study.","volume":"86","author":"Mok","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1136\/ard.2008.101766_bib48","first-page":"373","article-title":"The Systemic Lupus International Collaborating Clinics\/American College of Rheumatology (SLICC\/ACR) damage index for systemic lupus erythematosus international comparison.","volume":"27","author":"Gladman","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.101766_bib49","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1191\/0961203302lu203ra","article-title":"Protective effect of hydroxychloroquine in systemic lupus erythematosus. Prospective long-term study of an Israeli cohort.","volume":"11","author":"Molad","year":"2002","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib50","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/art.21039","article-title":"Systemic lupus erythematosus in three ethnic groups: XVI. Association of hydroxychloroquine use with reduced risk of damage accrual.","volume":"52","author":"Fessler","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.101766_bib51","first-page":"41","article-title":"The central role of propensity scores in estimating dose-response functions.","volume":"70","author":"Rosembaum","year":"1983","journal-title":"Biometrika"},{"key":"10.1136\/ard.2008.101766_bib52","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/ard.2006.068676","article-title":"Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L).","volume":"66","author":"Alarc\u00f3n","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.101766_bib53","first-page":"395","article-title":"Risk factors associated with mortality in systemic lupus erythematosus. A case-control study in a tertiary care center in Mexico City.","volume":"19","author":"Hern\u00e1ndez-Cruz","year":"2001","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2008.101766_bib54","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1002\/art.21358","article-title":"Double-blind, randomized, controlled clinical trial of clofazimine compared with chloroquine in patients with systemic lupus erythematosus.","volume":"52","author":"Bezerra","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.101766_bib55","first-page":"808","article-title":"Discontinuation of antimalarial drugs in systemic lupus erythematosus.","volume":"26","author":"Wang","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.101766_bib56","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1136\/ard.51.12.1318","article-title":"Continuation of long term treatment with hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis.","volume":"51","author":"Morand","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.101766_bib57","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/ard.57.10.582","article-title":"Long-term effectiveness of antimalarial drugs in rheumatic diseases.","volume":"57","author":"Avi\u00f1a-Zubieta","year":"1998","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.101766_bib58","first-page":"52","article-title":"Ocular side effects of chloroquine in patients with rheumatoid arthritis, systemic lupus erythematosus and scleroderma.","volume":"90","author":"Leecharoen","year":"2007","journal-title":"J Med Assoc Thai"},{"key":"10.1136\/ard.2008.101766_bib59","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0161-6420(03)00409-3","article-title":"The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.","volume":"110","author":"Mavrikakis","year":"2003","journal-title":"Ophthalmology"},{"key":"10.1136\/ard.2008.101766_bib60","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/art.1780400817","article-title":"Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice.","volume":"40","author":"Levy","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.101766_bib61","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0002-9394(87)90005-5","article-title":"Hydroxychloroquine therapy in massive total doses without retinal toxicity.","volume":"104","author":"Johnson","year":"1987","journal-title":"Am J Ophthalmol"},{"key":"10.1136\/ard.2008.101766_bib62","first-page":"692","article-title":"Comparison of hydroxychloroquine and chloroquine use and the development of retinal toxicity.","volume":"12","author":"Finbloom","year":"1985","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.101766_bib63","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archopht.1982.01030030845024","article-title":"Safety of hydroxychloroquine.","volume":"100","author":"Frenkel","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"10.1136\/ard.2008.101766_bib64","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1442-9071.2006.01167.x","article-title":"Retinal nerve fibre layer thickness measurements in patients using chloroquine.","volume":"34","author":"Bonanomi","year":"2006","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1136\/ard.2008.101766_bib65","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1177\/096120339300200604","article-title":"Hydroxychloroquine, dosage parameters and retinopathy.","volume":"2","author":"Spalton","year":"1993","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib66","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/rheumatology\/kel402","article-title":"Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases.","volume":"46","author":"Costedoat-Chalumeau","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2008.101766_bib67","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1191\/0961203306lu2345oa","article-title":"The cardiac safety of chloroquine phosphate treatment in patients with systemic lupus erythematosus: the influence on arrhythmia, heart rate variability and repolarization parameters.","volume":"15","author":"Wozniacka","year":"2006","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib68","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1191\/0961203304lu514oa","article-title":"Factors associated with chloroquine-induced retinopathy in rheumatic diseases.","volume":"13","author":"Araiza-Casillas","year":"2004","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib69","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1136\/ard.60.3.301","article-title":"Cardiac toxicity secondary to long term treatment with chloroquine.","volume":"60","author":"Cervera","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.101766_bib70","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/art.10054","article-title":"How frequently and how soon should we screen our patients for the presence of antimalarial retinopathy?","volume":"46","author":"Alarc\u00f3n","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.101766_bib71","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/1529-0131(200108)44:8<1959::AID-ART334>3.0.CO;2-A","article-title":"Early hydroxychloroquine macular toxicity.","volume":"44","author":"Warner","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.101766_bib72","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0002-9394(14)76853-9","article-title":"Hydroxychloroquine retinopathy.","volume":"112","author":"Weiner","year":"1991","journal-title":"Am J Ophthalmol"},{"key":"10.1136\/ard.2008.101766_bib73","first-page":"2703","article-title":"Hydroxychloroquine retinopathy despite regular ophthalmologic evaluation: a consecutive series.","volume":"27","author":"Bienfang","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.101766_bib74","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0161-6420(02)01168-5","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy: a report by the American Academy of Ophthalmology.","volume":"109","author":"Marmor","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1136\/ard.2008.101766_bib75","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1056\/NEJM198809223191207","article-title":"Weekly clinicopathological exercises. Case 38\u20131988. A 58-year-old woman with fever, sweats, congestive heart failure, and lymphadenopathy after treatment for a diagnosis of systemic lupus erythematosus.","volume":"319","author":"Case records of the Massachusetts General Hospital","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.101766_bib76","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/15563650500514558","article-title":"Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia.","volume":"44","author":"Chen","year":"2006","journal-title":"Clin Toxicol"},{"key":"10.1136\/ard.2008.101766_bib77","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1191\/096120301673172543","article-title":"Complete heart block in an adult with systemic lupus erythematosus and recent onset of hydroxychloroquine therapy.","volume":"10","author":"Com\u00edn-Colet","year":"2001","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib78","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.echo.2005.01.012","article-title":"Hydroxychloroquine-induced cardiotoxicity in a 39-year-old woman with systemic lupus erythematosus and systolic dysfunction.","volume":"18","author":"Keating","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1136\/ard.2008.101766_bib79","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.semarthrit.2003.09.012","article-title":"Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature.","volume":"33","author":"Nord","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.2008.101766_bib80","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1056\/NEJM198701223160405","article-title":"Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy.","volume":"316","author":"Ratliff","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2008.101766_bib81","first-page":"953","article-title":"Chloroquine-induced cardiomyopathy.","volume":"111","author":"McAllister","year":"1987","journal-title":"Arch Pathol Lab Med"},{"key":"10.1136\/ard.2008.101766_bib82","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.echo.2004.09.029","article-title":"Chloroquine-induced cardiomyopathy-echocardiographic features.","volume":"18","author":"Naqvi","year":"2005","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1136\/ard.2008.101766_bib83","first-page":"1642","article-title":"Hydroxychloroquine myopathy.","volume":"25","author":"Richards","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.101766_bib84","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s002960000066","article-title":"Hydroxychloroquine-induced seizure in a patient with systemic lupus erythematosus.","volume":"20","author":"Malcangi","year":"2000","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard.2008.101766_bib85","first-page":"65","article-title":"Diplopia in a patient under hydroxychloroquine for systemic lupus erythematosus.","volume":"64","author":"Sabbagh","year":"1997","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1136\/ard.2008.101766_bib86","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/mus.880110205","article-title":"Chloroquine myopathy and myasthenia-like syndrome.","volume":"11","author":"Sghirlanzoni","year":"1988","journal-title":"Muscle Nerve"},{"key":"10.1136\/ard.2008.101766_bib87","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00296-003-0435-8","article-title":"Seizure associated with chloroquine therapy in a patient with systemic lupus erythematosus.","volume":"24","author":"Tristano","year":"2004","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard.2008.101766_bib88","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1468-3083.2006.01494.x","article-title":"Hydroxychloroquine-induced pigmentation in two patients with systemic lupus erythematosus.","volume":"20","author":"Reynaert","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1136\/ard.2008.101766_bib89","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/1529-0131(199804)41:4<744::AID-ART26>3.0.CO;2-F","article-title":"Antimalarial drug-induced aquagenic-type pruritus in patients with lupus.","volume":"41","author":"Jim\u00e9nez-Alonso","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.101766_bib90","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/000155599750010850","article-title":"Hydroxychloroquine-induced pruritus.","volume":"79","author":"Holme","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1136\/ard.2008.101766_bib91","first-page":"472","article-title":"Ototoxicity due to hydroxychloroquine: report of two cases.","volume":"16","author":"Johansen","year":"1998","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.2008.101766_bib92","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00277-006-0249-3","article-title":"Secondary myelodysplastic syndrome after hydroxychloroquine therapy.","volume":"86","author":"Muslimani","year":"2007","journal-title":"Ann Hematol"},{"key":"10.1136\/ard.2008.101766_bib93","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gut.35.4.569","article-title":"Fulminant hepatic failure secondary to hydroxychloroquine.","volume":"35","author":"Makin","year":"1994","journal-title":"Gut"},{"key":"10.1136\/ard.2008.101766_bib94","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-2007-999371","article-title":"Pregnancy outcome following first trimester exposure to chloroquine.","volume":"8","author":"Levy","year":"1991","journal-title":"Am J Perinatol"},{"key":"10.1136\/ard.2008.101766_bib95","first-page":"1715","article-title":"Hydroxychloroquine in pregnant patients with systemic lupus erythematosus.","volume":"23","author":"Parke","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.2008.101766_bib96","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/ard.55.7.486","article-title":"Hydroxychloroquine and lupus pregnancy: review of a series of 36 cases.","volume":"55","author":"Buchanan","year":"1996","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.2008.101766_bib97","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(01)06004-4","article-title":"Ocular toxicity and antenatal exposure to chloroquine or hydroxychloroquine for rheumatic diseases.","volume":"358","author":"Klinger","year":"2001","journal-title":"Lancet"},{"key":"10.1136\/ard.2008.101766_bib98","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/art.11304","article-title":"Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group.","volume":"48","author":"Costedoat-Chalumeau","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.101766_bib99","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1191\/0961203304lu528oa","article-title":"Chloroquine gestational use in systemic lupus erythematosus: assessing the risk of child ototoxicity by pure tone audiometry.","volume":"13","author":"Borba","year":"2004","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib100","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/sj.jp.7211208","article-title":"Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation.","volume":"25","author":"Motta","year":"2005","journal-title":"J Perinatol"},{"key":"10.1136\/ard.2008.101766_bib101","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1002\/art.20648","article-title":"Electroretinograms of children born to mothers treated with hydroxychloroquine during pregnancy and breast-feeding: comment on the article by Costedoat-Chalumeau et al","volume":"50","author":"Cimaz","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2008.101766_bib102","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0961203307078579","article-title":"Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus.","volume":"16","author":"James","year":"2007","journal-title":"Lupus"},{"key":"10.1136\/ard.2008.101766_bib103","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/ard.2006.067777","article-title":"Antimalarials may influence the risk of malignancy in systemic lupus erythematosus.","volume":"66","author":"Ruiz-Irastorza","year":"2007","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724196495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724196495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2008.101766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T09:14:11Z","timestamp":1736068451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724196495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0003496724196495"],"URL":"https:\/\/doi.org\/10.1136\/ard.2008.101766","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2008.101766","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Published by Elsevier Inc. Publishing Group Ltd and European League Against Rheumatism. All rights reserved. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}